Riverwater Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Riverwater Partners's LMAT Position: Q3 2026 in Review
Riverwater Partners held its LeMaitre Vascular (LMAT) position steady in Q3 2026 at 22,593 shares worth $1.87M. The position accounts for 0.52% of the portfolio, ranked #71.
Riverwater Partners first reported a position in LMAT in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.89M in Q3 2024. 242 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Riverwater Partners held 22,593 shares of LeMaitre Vascular worth $1.87M as of Q3 2026.
- Riverwater Partners left its LeMaitre Vascular share count unchanged in Q3 2026.
- LeMaitre Vascular made up 0.52% of Riverwater Partners's portfolio in Q3 2026, its #71 holding.
- Riverwater Partners first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 19 quarters since.
- Riverwater Partners's LeMaitre Vascular position peaked at $2.89M in Q3 2024.
- 242 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Riverwater Partners's 13F filing for Q3 2026, filed 3 Nov 2026.